Dicerna Pharmaceuticals I...

NASDAQ: DRNA · Real-Time Price · USD
38.22
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Dicerna Pharmaceuticals Revenue

Dicerna Pharmaceuticals reported an annual revenue of $164.31M, reflecting a 587.36% growth. For the quarter ending September 30, 2021, Dicerna Pharmaceuticals generated $62.95M in revenue.
Revenue (ttm)
164.31M
Revenue Growth
587.36%
Price / Sales Ratio
9.99
Revenue / Employee
544.06K
Employees
302
Market Cap
0

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2020 164.31M +587.36%
Dec 31, 2019 23.9M +287.05%
Dec 31, 2018 6.18M +171.23%
Dec 31, 2017 2.28M +671.86%
Dec 31, 2016 295K +60.33%
Dec 31, 2015 184K +Infinity%
Dec 31, 2014 0 n/a
Dec 31, 2013 0 -100.00%
Dec 31, 2012 7.01M -11.29%
Dec 31, 2011 7.91M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.